4DMedical Limited (ASX:4DX) Secures $22.6M Through Option Exercises
4DMedical (ASX:4DX) raises $22.6 million through option exercises, enhancing its cash position to $45.5 million for strategic growth.
Tag: Corporate Strategy & Guidance
Eureka Group Holdings Limited (ASX:EGH) Acquires Hillside Garden Village in Perth
Eureka Group Holdings (ASX:EGH) acquires Hillside Garden Village in Perth for $22.15m, expanding its portfolio by 29%.
Race Oncology (ASX:RAC) Discovers RCDS1 Mechanism of Action
Race Oncology (ASX:RAC) announces the discovery of RCDS1’s primary anticancer mechanism, enhancing its clinical and commercial potential.
Webjet Group (ASX:WJL) Completes Locomote Acquisition
Webjet Group (ASX:WJL) finalises $23 million acquisition of Locomote, enhancing its business travel technology platform.
Yandal Resources (ASX:YRL) Announces $13.5M Placement to Expand Exploration
Yandal Resources (ASX:YRL) raises $13.5M in placement to accelerate its exploration programs, supported by major shareholders.
Eagers Automotive (ASX:APE) Acquires CanadaOne Auto Group
Eagers Automotive (ASX:APE) acquires CanadaOne Auto Group for C$2.145 billion, expanding its market presence.
Ryzon Materials Ltd (ASX:RYZ) Expands Engineering Agreement and Secures Capital Raising with Xinhai
Ryzon Materials (ASX:RYZ) expands engineering agreement and raises capital with Xinhai to advance the Nachu Graphite Project.
OzAurum Resources Limited (ASX:OZM) Accelerates Mulgabbie North Development with New RC Drilling Program
OzAurum Resources (ASX:OZM) initiates new RC drilling at Mulgabbie North, enhancing gold resource development amid record gold prices.
Altech Batteries (ASX:ATC) to Commence Selling Sodium Nickel Chloride Batteries with AMPower
Altech Batteries (ASX:ATC) to commence selling sodium nickel chloride batteries in Europe, Australia, and the USA through a partnership with AMPower.
Starpharma (ASX:SPL) Partners with Radiopharm Theranostics to Develop Radiotherapy Asset
Starpharma (ASX:SPL) announces a research and option agreement with Radiopharm Theranostics to develop a novel radiotherapy asset.